Cosignaling Molecules Around LIGHT-HVEM-BTLA: From Immune Activation to Therapeutic Targeting
Journal:
Current Molecular Medicine
Volume:
9
Page:
911-927
Author(s):
Christine Pasero, Alemseged Truneh and Daniel Olive
Heat Shock Protein 90 – a Potential Target in the Treatment of Human Acute Myelogenous Leukemia
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
761-776
Author(s):
H. Reikvam, E. Ersvær and O. Bruserud
Targeting JAK/STAT Signaling Pathway in Inflammatory Diseases
Journal:
Current Signal Transduction Therapy
Volume:
4
Page:
201-221
Author(s):
Charles Jay Malemud and Eric Pearlman
Towards Cure of CML: Why We Need to Know More About CML Stem Cells?
Journal:
Current Stem Cell Research & Therapy
Volume:
4
Page:
224-236
Author(s):
Jeroen J.W.M. Janssen, Gerrit J. Schuurhuis, Monique Terwijn and Gerrit J. Ossenkoppele
Vascular Endothelial Growth Factor Receptor 1, a Therapeutic Target in Cancer, Inflammation and Other Disorders
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
2890-2898
Author(s):
Yan Wu and Zhenping Zhu
The Effects of Tamoxifen on Immunity
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
3076-3080
Author(s):
S. Behjati and M. H. Frank
Anti-Apoptotic Genes in the Survival of Monocytic Cells During Infection
Journal:
Current Genomics
Volume:
10
Page:
306-317
Author(s):
Aurelia Busca, Mansi Saxena, Marko Kryworuchko and Ashok Kumar
Potential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy
Journal:
Current Genomics
Volume:
10
Page:
336-352
Author(s):
Mingqing Tang, William Xu, Qizhao Wang, Weidong Xiao and Ruian Xu
Expression and Function of Kruppel Like-Factors (KLF) in Carcinogenesis
Journal:
Current Genomics
Volume:
10
Page:
353-360
Author(s):
Christophe Bureau, Naima Hanoun, Jerome Torrisani, Jean-Pierre Vinel, Louis Buscail and Pierre Cordelier
Editorial [Hot Topic: Recombinant Immunotoxins – The Next Generation (Executive Editor: Stefan Barth)]
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2650-2651
Author(s):
Stefan Barth